Product Information
MIRTAZAPINE 45 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1108 per EA under NDC 57664050183. Its NADAC has been published 523 times since Sep 7, 2016.
FDA first approved this application on Apr 22, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
45 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664050183
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076541FDA Approved
4/22/2004
TE Code
AB
On Market Since
4/22/2004
Price Statistics
The NADAC for MIRTAZAPINE 45 MG TABLET has been published 523 times since Sep 7, 2016, and over the history we have for it it has declined 63.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1108 per EA |
|---|---|
| All-time high | $0.3084 (Nov 16, 2016) |
| All-time low | $0.0939 (Nov 20, 2024) |
| 52-week high | $0.1153 |
| 52-week low | $0.1049 |
| Median price | $0.1439 |
| Average price | $0.1631 |
| Largest weekly change | +23.5% (Aug 21, 2024) |
| Weeks tracked | 523 |
| Tracking since | Sep 7, 2016 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 45 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1108 per EA (NDC 57664050183), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 45 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 45 MG TABLET has declined 63.9%. It has been tracked across 523 weekly CMS publications since Sep 7, 2016.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 45 MG TABLET?
Since Sep 7, 2016, the NADAC for MIRTAZAPINE 45 MG TABLET has ranged from a low of $0.0939 (Nov 20, 2024) to a high of $0.3084 (Nov 16, 2016), with a median of $0.1439 per EA.
Are there cheaper alternatives to MIRTAZAPINE 45 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIRTAZAPINE 45 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIRTAZAPINE 45 MG TABLET?
MIRTAZAPINE 45 MG TABLET (NDC 57664050183) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.